Hemophilia A subjects with an intron-22 gene inversion mutation show CD4+ T-effector responses to multiple epitopes in FVIII
BackgroundAlmost half of severe hemophilia A (HA) is caused by an intron 22 inversion mutation (Int22Inv), which disrupts the 26-exon F8 gene. Inverted F8 mRNA exons 1-22 are transcribed, while F8B mRNA, containing F8 exons 23-26, is transcribed from a promoter within intron 22. Neither FVIII activi...
Main Authors: | Devi Gunasekera, Pooja Vir, Ahmad Faisal Karim, Margaret V. Ragni, Kathleen P. Pratt |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1128641/full |
Similar Items
-
Factor VIII inhibitor development in Egyptian hemophilia patients: does intron 22 inversion mutation play a role?
by: Laila M. Sherief, et al.
Published: (2020-09-01) -
Large Intron Inversions in Romanian Patients with Hemophilia A—First Report
by: Melen Brinza, et al.
Published: (2023-10-01) -
Prominent Mutation of Intron 22 Inversion in Sporadic Hemophilia: Is It Worth the Antenatal Screening?
by: Sasanakul W, et al.
Published: (2022-05-01) -
Factor VIII-Intron 1 Inversion of Hemophilia A Patients In West Anatolia
by: Pehlivan M, et al.
Published: (2007-04-01) -
Comparative evaluation of the safety and efficacy of recombinant FVIII in severe hemophilia A patients
by: Hassan Abolghasemi, MD, et al.
Published: (2018-06-01)